The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published in Vaccine. The U.S. Food and Drug Administration approved PCV13 for use beginning in 2010 after a series of trials...
More...
More...